Acro Biomedical (ACBM) Return on Sales (2017 - 2023)

Acro Biomedical's Return on Sales history runs 7 years deep, the most recent figure standing at 0.35% for Q3 2023.

• In Q3 2023, Return on Sales fell 18.0% year-over-year to 0.35%; the TTM figure through Sep 2023 stood at 0.35% (down 18.0% YoY), while the FY2022 annual figure was 0.24%, down 18.0% from the prior year.
• Return on Sales was 0.35% for Q3 2023 at Acro Biomedical, up from 0.42% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.0% in Q1 2020 to a low of 0.44% in Q1 2023.
• Historically, Return on Sales has averaged 0.12% across 5 years, with a median of 0.06% in 2021.
• The sharpest annual moves came in 2019 and 2023: Return on Sales changed 0 bps in 2019, then sank 31 bps in 2023.
• A 5-year view of Return on Sales shows it stood at 0.0% in 2019, then soared by 62 bps to 0.0% in 2020, then sank by 4213 bps to 0.06% in 2021, then slumped by 70 bps to 0.11% in 2022, then tumbled by 223 bps to 0.35% in 2023.
• The last three Return on Sales figures came in at 0.35% (Q3 2023), 0.42% (Q2 2023), and 0.44% (Q1 2023), per Business Quant data.